EMIS Group is a clinical software supplier to the UK healthcare market. The company was originally established to serve the GP market, where it has a leading position with a market share of 57% of UK GP practices. It has expanded from this position to create a broad range of products serving the community healthcare market, the acute sector and community pharmacies (where it has c 37% share). Its Patient business provides medical and wellbeing information as well as transactional services to patients. The company strategy is to provide connected healthcare solutions to facilitate patient-centric care.
In this audio interview, CEO Andy Thorburn reviews the group’s financial and operational highlights for H120 and gives an overview of performance on a divisional basis. He talks about the impact of COVID-19 on the business so far this year and how he expects it to influence the business in H2. Discussing product development, he confirms continued development of the EMIS-X platform as well as the introduction of specific solutions to help the fight against COVID-19. With a strong cash position at the end of H1, Andy explains the company is well positioned to navigate through the current uncertainty and suggests the potential for M&A. Finally, he discusses the current trading environment and gives his views on the company’s short- and medium-term outlook.